Literature DB >> 1334710

Secretion of thioredoxin after in vitro activation of human B cells.

M L Ericson1, J Hörling, V Wendel-Hansen, A Holmgren, A Rosén.   

Abstract

The redox-active enzyme thioredoxin (Trx) is secreted by various virus-transformed cell lines of B- and T-cell origin and has been considered to play an autoregulatory role as a cofactor during cellular growth processes. We show in this paper that exposure of B lymphocytes from normal, healthy donors and B cells from B-type chronic lymphocytic leukemia (B-CLL) to Staphylococcus aureus Cowan I (SAC) induced expression of Trx mRNA. By combining SAC, or the phorbol ester TPA, with IL-2 and the conditioned medium of a T-cell hybridoma (BSF-MP6), we could strongly enhance the Trx expression. After [35S]methionine labeling of stimulated B-CLL cells in vitro, Trx was immunoprecipitated both from cell extracts and from the medium with antibodies against human placenta Trx. Secretion of newly synthesized Trx was also confirmed by a quantitative radioimmunoassay for human Trx. During 24 h cultivation experiments, treatment with SAC induced a 5-fold increase of the Trx content of normal B lymphocytes as well as in B-CLL cells. Approximately two-thirds of the total amount of the enzyme was released into the medium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334710

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  13 in total

1.  Cynoglossus semilaevis thioredoxin: a reductase and an antioxidant with immunostimulatory property.

Authors:  Jin-sheng Sun; Yong-xin Li; Li Sun
Journal:  Cell Stress Chaperones       Date:  2012-01-18       Impact factor: 3.667

Review 2.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

Review 3.  Growth and survival of B-chronic lymphocytic leukaemia cells.

Authors:  O Söderberg
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

4.  Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina.

Authors:  Kunihisa Miwa; Chiharu Kishimoto; Hajime Nakamura; Toshinori Makita; Katsuhisa Ishii; Nobuaki Okuda; Ataru Taniguchi; Keisuke Shioji; Juni Yodoi; Shigetake Sasayama
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

5.  Identification and characterization of novel variants of the thioredoxin reductase 3 new transcript 1 TXNRD3NT1.

Authors:  Yasunari Matsuzaka; Koichi Okamoto; Tomotaka Mabuchi; Mariko Iizuka; Akira Ozawa; Akira Oka; Gen Tamiya; Jerzy K Kulski; Hidetoshi Inoko
Journal:  Mamm Genome       Date:  2005-01       Impact factor: 2.957

6.  Overexpression of thioredoxin-1 reduces oxidative stress in the placenta of transgenic mice and promotes fetal growth via glucose metabolism.

Authors:  Takashi Umekawa; Takashi Sugiyama; Tomohisa Kihira; Nao Murabayashi; Lingyun Zhang; Kenji Nagao; Yuki Kamimoto; Ning Ma; Junji Yodoi; Norimasa Sagawa
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 7.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

8.  Redox proteins are constitutively secreted by skeletal muscle.

Authors:  Yasuko Manabe; Mayumi Takagi; Mio Nakamura-Yamada; Naoko Goto-Inoue; Masato Taoka; Toshiaki Isobe; Nobuharu L Fujii
Journal:  J Physiol Sci       Date:  2014-09-10       Impact factor: 2.781

9.  Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.

Authors:  Changping Li; Michael A Thompson; Archito T Tamayo; Zhuang Zuo; John Lee; Francisco Vega; Richard J Ford; Lan V Pham
Journal:  Oncotarget       Date:  2012-03

10.  Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells.

Authors:  R Bertini; O M Howard; H F Dong; J J Oppenheim; C Bizzarri; R Sergi; G Caselli; S Pagliei; B Romines; J A Wilshire; M Mengozzi; H Nakamura; J Yodoi; K Pekkari; R Gurunath; A Holmgren; L A Herzenberg; L A Herzenberg; P Ghezzi
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.